Company
Athenex
Athenex has 11 drugs tracked on RxWires: 1 in Phase 3, 1 in Phase 2, 9 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Oraxol | Phase 3 | Metastatic Breast Cancer |
| KX2-391 | Phase 2 | Bone-Metastatic, Castration-Resistant Prostate Cancer |
| PT01 (Pegtomarginase) | Phase 1 | Advanced Solid Malignancies |
| KUR-502 | Phase 1 | NHL, Relapsed, Adult |
| Oradoxel | Phase 1 | Solid Tumor |
| KX2-391 Ointment 1% | Phase 1 | Actinic Keratoses |
| KX2-361 | Phase 1 | Advance Malignancies |
| HM30181 methanesulfonate monohydrate plus oral paclitaxel capsules | Phase 1 | Solid Tumor |
| TCRT-ESO-A2 | Phase 1 | Advanced Solid Tumor |
| Oratopo | Phase 1 | Solid Tumor |
| Oratecan | Phase 1 | Solid Tumor |
Latest
No recent events.
Follow Athenex on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.